Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AgfiledCriticalBayer Ag
Publication of BE752986ApublicationCriticalpatent/BE752986A/fr
B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
B01J49/00—Regeneration or reactivation of ion-exchangers; Apparatus therefor
B01J49/60—Cleaning or rinsing ion-exchange beds
C—CHEMISTRY; METALLURGY
C01—INORGANIC CHEMISTRY
C01B—NON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
C01B32/00—Carbon; Compounds thereof
C01B32/30—Active carbon
C01B32/354—After-treatment
C01B32/36—Reactivation or regeneration
Landscapes
Chemical & Material Sciences
(AREA)
Organic Chemistry
(AREA)
Chemical Kinetics & Catalysis
(AREA)
Inorganic Chemistry
(AREA)
Treatment Of Water By Ion Exchange
(AREA)
BE752986D1969-07-041970-07-03Procede pour le traitement des masses d'echangeurs d'ions et decharbonsactifs, chargees d'impuretes microbiennes
BE752986A
(fr)
Nouveau médicament notamment pour le traitement de l'andropause, de la sénescence et des troubles de l'anabolisme protéique et de l'édification cellulaire.